Validation of serum tumor biomarkers in predicting advanced cystic mucinous neoplasm of the pancreas

Abstract

CA19-9 has a moderate ability, and CEA, CA125, and CA724 have a low ability to predict A-cMNs. The combination of STM testing could improve SE in predicting A-cMNs.